FILREVY Trademark

Trademark Overview

On Thursday, February 7, 2013, a trademark application was filed for FILREVY with the United States Patent and Trademark Office. The USPTO has given the FILREVY trademark a serial number of 85843213. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 15, 2017. This trademark is owned by Novartis AG. The FILREVY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system and the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, hematology and oncology; Pharmaceutical preparations for use in transplantation; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for use in the gastroenterological areas and for the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations, namely, anti-infectives; pharmaceutical preparations for treating bacterial-based diseases; Pharmaceutical preparations, namely, antivirals, antibiotics and antifungals
filrevy

General Information

Serial Number85843213
Word MarkFILREVY
Filing DateThursday, February 7, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 15, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 11, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system and the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, hematology and oncology; Pharmaceutical preparations for use in transplantation; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for use in the gastroenterological areas and for the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations, namely, anti-infectives; pharmaceutical preparations for treating bacterial-based diseases; Pharmaceutical preparations, namely, antivirals, antibiotics and antifungals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 13, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, May 15, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 15, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 26, 2016EXTENSION 5 GRANTED
Wednesday, October 5, 2016EXTENSION 5 FILED
Wednesday, October 5, 2016TEAS EXTENSION RECEIVED
Thursday, April 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 13, 2016EXTENSION 4 GRANTED
Tuesday, April 5, 2016EXTENSION 4 FILED
Tuesday, April 5, 2016TEAS EXTENSION RECEIVED
Wednesday, October 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 6, 2015EXTENSION 3 GRANTED
Sunday, October 4, 2015EXTENSION 3 FILED
Sunday, October 4, 2015TEAS EXTENSION RECEIVED
Tuesday, May 12, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 11, 2015EXTENSION 2 GRANTED
Sunday, April 5, 2015EXTENSION 2 FILED
Monday, May 11, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, April 5, 2015TEAS EXTENSION RECEIVED
Tuesday, October 7, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 3, 2014EXTENSION 1 GRANTED
Friday, October 3, 2014EXTENSION 1 FILED
Friday, October 3, 2014TEAS EXTENSION RECEIVED
Tuesday, April 8, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 22, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, December 28, 2013ASSIGNED TO LIE
Wednesday, December 4, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 19, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 19, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 19, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 22, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 22, 2013NON-FINAL ACTION E-MAILED
Wednesday, May 22, 2013NON-FINAL ACTION WRITTEN
Wednesday, May 15, 2013ASSIGNED TO EXAMINER
Wednesday, February 13, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 11, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

filrevy pharmaceutical preparations system disorders treatment prevention diseases namely anti ocular